[Arterial hypertension in immigrant patients in Spanish primary health care]. / Prevalencia de la hipertensión arterial en la población inmigrante asistida en atención primaria en España.

BACKGROUND AND OBJECTIVE: To evaluate the arterial hypertension (AHT) prevalence in a wide sample of immigrant patients. PATIENTS AND METHOD: A transversal and multicentric study that has included immigrant patients aged 18 years or more, consecutive sampling recruitment in primary healthcare consultations. The patient was defined with AHT hypertension when the average of 6 measurements in 3 visits (2 measurements per visit) was > or = 140 mmHg for the systolic blood pressure and/or 90 mmHg for diastolic blood pressure or if the patient had been previously diagnosed. RESULTS: 1,424 immigrants were followed-up (53.1% women) with average age (standard deviation) of 42.8 (13.1) years and mean stay in our country of 5.6 (5.7) years. Most of the patients' origin was Central and South America (40.2%) and Eastern Europe (21.9%). The prevalence of AHT was 31.4% (95% confidence interval [CI], 30.1-32.7%), of which the 62.1% where known patients. Patients coming from Asia showed a significant higher prevalence of AHT (40.0%; 95% CI, 38.7-41.3). CONCLUSIONS: Three of each 10 immigrant patients have AHT. There are significant differences according to the gender, the origin and period of residence of these patients.

Prevalencia de la hipertensión arterial en la población inmigrante asistida en atención primaria en España / Arterial hypertension in immigrant patients in Spanish primary health care

Fundamento y objetivo: Valorar la prevalencia de hipertensión arterial (HTA) en una amplia muestra de pacientes inmigrantes. Pacientes y método: Se ha realizado un estudio transversal y multicéntrico en pacientes inmigrantes de 18 años o más seleccionados consecutivamente en consultas de atención primaria de toda España. Se consideró que el paciente presentaba HTA cuando el promedio de 6 medidas de presión arterial en 3 visitas (2 tomas por visita) era igual o mayor de 140 mmHg para la sistólica y/o 90 mmHg para la diastólica, o cuando estaba diagnosticado de tal enfermedad. Resultados: Se estudió a 1.424 inmigrantes (un 53,1% mujeres) con una edad media (desviación estándar) de 42,8 (13,1) años y estancia media en nuestro país de 5,6 (5,7) años. La mayoría procedía de América Central y del Sur (40,2%) y Europa del Este (21,9%). La prevalencia de HTA fue del 31,4% (intervalo de confianza [IC] del 95%, 30,1-32,7%); de éstos, el 62,1% sabía que era hipertenso. Los individuos que procedían de Asia presentaban una prevalencia de HTA significativamente mayor (40,0%; IC del 95%, 38,7-41,3%). Conclusiones: Tres de cada 10 pacientes inmigrantes tienen HTA. Se observan diferencias según el sexo, la procedencia y el tiempo de estancia de los individuos

Background and objective: To evaluate the arterial hypertension (AHT) prevalence in a wide sample of immigrant patients. Patients and method: A transversal and multicentric study that has included immigrant patients aged 18 years or more, consecutive sampling recruitment in primary healthcare consultations. The patient was defined with AHT hypertension when the average of 6 measurements in 3 visits (2 measurements per visit) was >= 140 mmHg for the systolic blood pressure and/or 90 mmHg for diastolic blood pressure or if the patient had been previously diagnosed. Results: 1,424 immigrants were followed-up (53.1% women) with average age (standard deviation) of 42.8 (13.1) years and mean stay in our country of 5.6 (5.7) years. Most of the patients' origin was Central and South America (40.2%) and Eastern Europe (21.9%). The prevalence of AHT was 31.4% (95% confidence interval [CI], 30.1-32.7%), of which the 62.1% where known patients. Patients coming from Asia showed a significant higher prevalence of AHT (40.0%; 95% CI, 38.7-41.3). Conclusions: Three of each 10 immigrant patients have AHT. There are significant differences according to the gender, the origin and period of residence of these patients

Cumplimiento terapéutico y calidad de vida en pacientes crónicos / Therapeutic compliance and quality of life in chronic patients

Objetivo. Conocer el cumplimiento terapéutico y percepción de salud en dos Centros de Salud, en los que se utilizó un documento normalizado de tratamiento. Diseño. Ensayo clínico. Emplazamiento. Zonas de Salud de Sillería y Ocaña (Toledo). Participantes. Pacientes, de edad ≥ 18 años, en cartera de servicios que siguen tratamiento para la hipertensión, dislipemia y Diabetes Mellitus. Se realizó un muestreo aleatorio simple de los listados de estos pacientes. Mediciones principales. En los dos grupos se entregó un documento sobre medidas higiénico-dietéticas y consejos de cumplimentación farmacológica. En el grupo de intervención además del documento anterior se entregó una hoja de tratamientos crónicos. Se realizaron cuatro visitas bimensuales en un periodo de seguimiento de ocho meses. Para el estudio del cumplimento terapéutico se utilizó el recuento de comprimidos. En la primera y última visita se pasó la versión española del EuroQol-5D. Resultados. Se incluyeron en el estudio 309 pacientes con una edad media de 69,2 ± 10,7 años (55,3% eran mujeres). Un total de 156 pacientes fueron aleatorizados al grupo de intervención y 153 al grupo control. En la última visita 173 pacientes cumplieron adecuadamente el tratamiento (63,1%; IC 95%: 57,4 - 68,8), frente a 152 en la visita basal del estudio (55,5%; IC 95%: 49,6 - 61,4), Chi-cuadrado = 96,7 y p < 0,0001. Al analizar el número de pacientes cumplidores por grupo de estudio, en la visita fi nal, no se encontraron diferencias signifi cativas entre ambos grupos. Los grupos del estudio no mostraron diferencias en la percepción de su propia salud. Conclusiones. El documento normalizado de tratamiento no aportó una mejora en el cumplimiento terapéutico del grupo de intervención. La intervención realizada en ambos grupos y el seguimiento mejoró el cumplimiento terapéutico en ambos grupos (AU)

Objective. To determine treatment compliance and health perception at two Primary Health Centres, in which a standardized treatment protocol was used. Design. Clinical trial. Setting. Primary Health Centres at Sillería and Ocaña (Toledo). Subjects. Patients aged ≥ 18 years, in the portfolio services being treated for hypertension, dyslipidaemia and diabetes. A simple random sampling from the lists of these patients was made. Main measurement. Patients in both groups were given a sheet setting out health-dietary measures and advice on treatment compliance. The intervention group were also given a sheet of chronic treatments.. There were four two-monthly visits over a follow-up period of eight months. Pill count was used to determine treatment compliance. At the fi rst and last visit the Spanish version of the EuroQol- 5D was performed. Results. A total of 309 patients with an average age of 69.2 ± 10.7 years were included in the study (55.3% were women). Of these patients, 156 patients were randomised to the intervention group and 153 to the control group. At the final visit, 173 patients had good treatment compliance (63.1%; CI 95%, 57.4 - 68.8), as opposed to 152 at the baseline visit (55.5%; CI 95%, 49.6 - 61.4), Chi-square = 96.7 and p < 0,0001. At the final visit, no significant differences were found between the two groups as regards treatment compliance. There were no differences in health perception between the two study groups. Conclusions. The standardized treatment document did not contribute to an improvement in treatment compliance in the intervention group. Interventionand follow-up improved treatment compliance in both groups (AU)